Rachana Govind Hublikar, Sadhana N Holla, Cheshmitha Minnamreddigari
Rachana Govind Hublikar1, Sadhana N Holla2*, Cheshmitha Minnamreddigari3
1Junior Pharmacovigilance Associate, Indegene Pvt. Ltd. 3rd Floor, Aspen G-4 Block, MEBP (SEZ), Nagawara, Bangalore – 560045.
2Associate Professor, Department of Pharmacology, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka – 576104.
3MSc Graduate, Department of Microbiology, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka – 576104.
Volume - 16,
Issue - 5,
Year - 2023
Ulcerative colitis (UC) manifests as chronic inflammation of the colon. The bowel inflammation is due to alteration in the immune response to gut micro flora, oxidative stress and hereditary genetic factors. Leaf extract of papaya Carica papaya Linn. contain vitamin A, C, alkaloids, saponins, glycosides, tannins and flavonoids which have antispasmodic, analgesic, antibacterial and antioxidant properties. The main aim of the study was to detect the efficacy of Carica papaya leaf extract (PLE) on ulcerative colitis in Wistar Albino rats with objectives to explore the possible mechanism involved in its efficacy and to look for prebiotic activity. The project was initiated after the approval of Institutional Animal Ethics Committee. Thirty adult Wistar rats were randomly assigned into seven groups of six rats each. Group I-control, Group II-UC disease control, Group III-Disease with standard Sulfasalazine 100mg/kg, Group IV and Group V, UC disease model receiving PLE of 250mg/kg and 500 mg/kg respectively. Ulcerative colitis was not induced in Group VI and Group VII which received PLE of 500mg/kg and 700 mg/kg respectively. All the drugs were administered orally for 15 days. UC was induced by acetic acid on the 8th day. Blood sample was collected for biochemical analysis for antioxidant levels. Histopathological analysis of distal colon was performed to look for inflammatory features. Microbial analysis was done for group VI and group VII. There was significant reduction in body weight in UC induced groups when compared to control. The weight loss in Group IV and V (PE1 and PE2) was not as extreme as seen in the UC alone group. The treatment groups IV and V showed significant increase in protein levels, increased catalase and decreased malondialdehyde levels when compared to Group I, II and III. On histopathological analysis, the severity and extent of inflammation was less in 500mg/kg dose of leaf extract (Group V) than 250mg/kg of leaf extract (Group IV) and 100mg/kg of sulfasalazine (Group III). Tissue sections of Group V showed only few inflammatory infiltrates with absence of oedema and crypt abscess in the submucosal area. On examining the pathogenic versus beneficial bacterial load in the control and Group VI (PE 3) and Group VII (PE 4), papaya leaf extracts depicted antibacterial property and probiotic activity. In the present study, 500mg/kg of papaya leaf extract was efficacious in relieving oxidative stress and reducing inflammation in acetic acid induced ulcerative colitis in rats. Carica papaya leaf extracts have a potential role to modify gut microbe with respect to its prebiotic activity.
Cite this article:
Rachana Govind Hublikar, Sadhana N Holla, Cheshmitha Minnamreddigari. Ameliorative effect of aqueous extract of Carica papaya Linn. leaves on Acetic acid induced Ulcerative Colitis in Male Albino Wistar rats. Research Journal of Pharmacy and Technology 2023; 16(5):2147-3. doi: 10.52711/0974-360X.2023.00353
Rachana Govind Hublikar, Sadhana N Holla, Cheshmitha Minnamreddigari. Ameliorative effect of aqueous extract of Carica papaya Linn. leaves on Acetic acid induced Ulcerative Colitis in Male Albino Wistar rats. Research Journal of Pharmacy and Technology 2023; 16(5):2147-3. doi: 10.52711/0974-360X.2023.00353 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2023-16-5-12
1. Adams SM, Bornemann PH. Ulcerative colitis. Am Fam Physician. 2013;87(10):699‐705.
2. Sandler R, Loftus E Jr. Clinical course and natural history of ulcerative colitis. In: Cantor M, Bernstein C N. Kirsner’s inflammatory bowel diseases. 6th edition. Philadelphia: Saunders; 2004. p. 280-288.
3. Sairenji T, Collins KL, Evans DV. An Update on Inflammatory Bowel Disease. Prim Care. 2017;44(4):673‐692.
4. Shin SK, Cho JH, Kim EJ, Kim E-K, Park DK, Kwon KA, et al. Anti-inflammatory and anti-apoptotic effects of rosuvastatin by regulation of oxidative stress in a dextran sulfate sodium-induced colitis model. World J Gastroenterol. 2017;23(25):4559.
5. Aravind G, Bhowmik D, Duraivel S, Harish G. Traditional and medicinal uses of Carica papaya. Journal of Medicinal Plants Studies. 2013;1(1):7-15.
6. Yogiraj V, Goyal PK, Chauhan CS, Goyal A, Vyas B. Carica papaya Linn: an overview. International Journal of Herbal Medicine. 2014; 2(5):01-8.
7. Ungaro R, Mehandru S, Allen PB, Pyrin- Biroulet L, Colombrl JF. Ulcerative colitis. Lancet. 2017;389(10080):1756-1770. doi: 10.1016/S0140-6736(16)32126-2.
8. Lee WT, Tung YT, Wu CC, Tu PS, Yen GC. Camellia oil (Camellia oleifera Abel.) modifies the composition of gut microbiota and alleviates acetic acid-induced colitis in rats. Journal of agricultural and food chemistry. 2018;66(28):7384-92.
9. Markowiak P, Śliżewska K. Effects of Probiotics, Prebiotics, and Synbiotics on Human Health. Nutrients. 2017;9(9):1021.
10. Shahid S, Fatima U. Pharmacological activities of Carica papaya Linn. Journal of Basic and Applied Sciences. 2018; 14:210-6.
11. Fabia R, Willen R, Ar’Rajab A, Andersson R, Ahren B, Bengmark S. Acetic acid-induced colitis in the rat: a reproducible experimental model for acute ulcerative colitis. European surgical research. 1992;24(4):211-25.
12. Dieleman LA, Palmen MJ, Akol H, Bloemena E, Peña AS, Meuwissen SG, Van Rees EP. Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immunol. 1998;114(3):385-91.
13. Warren S, Sommers SC. Pathogenesis of ulcerative colitis. The American journal of pathology. 1949;25(4):657.
14. Isgar B, Harman M, Kaye MD, Whorwell PJ. Symptoms of irritable bowel syndrome in ulcerative colitis in remission. Gut. 1983;24(3):190-2.
15. Amani S. Awaad, Reham M. El-Meligy, Gamal A. Soliman, Natural products in treatment of ulcerative colitis and peptic ulcer, Journal of Saudi Chemical Society, Volume 17, Issue 1,2013, Pages 101-124,
16. Owusu G, Obiri DD, Ainooson GK, Osafo N, Antwi AO, Duduyemi BM, Ansah C, "Acetic Acid-Induced Ulcerative Colitis in Sprague Dawley Rats Is Suppressed by Hydroethanolic Extract of Cordiavignei Leaves through Reduced Serum Levels of TNF-α and IL-6", International Journal of Chronic Diseases, vol. 2020, Article ID 8785497, 11 pages, 2020.
17. Balestrieri P, Ribolsi M, Guarino MPL, Emerenziani S, Altomare A, Cicala M. Nutritional Aspects in Inflammatory Bowel Diseases. Nutrients. 2020;12(2):372.
18. Khan N, Patel D, Shah Y, Trivedi C, Yang YX. Albumin as a prognostic marker for ulcerative colitis. World J Gastroenterol. 2017;23(45):8008-8016.
19. Lim XY, Chan JSW, Japri N, Lee JC, Tan TYC. Carica papaya L. Leaf: A Systematic Scoping Review on Biological Safety and Herb-Drug Interactions. Evid Based Complement Alternat Med. 2021;2021:5511221.
20. Kong YR, Jong YX, Balakrishnan M, Bok ZK, Weng JKK, Tay KC, Goh BH, Ong YS, Chan KG, Lee LH, Khaw KY. Beneficial Role of Carica papaya Extracts and Phytochemicals on Oxidative Stress and Related Diseases: A Mini Review. Biology (Basel). 2021;10(4):287.
21. Seril DN, Liao J, Yang GY, Yang CS. Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models. Carcinogenesis. 2003;24(3):353-62.
22. Roessner A, Kuester D, Malfertheiner P, Schneider-Stock R. Oxidative stress in ulcerative colitis-associated carcinogenesis. Pathology-Research and practice. 2008; 204(7):511-24.
23. Jena G, Trivedi PP, Sandala B. Oxidative stress in ulcerative colitis: an old concept but a new concern. Free radical research. 2012;46(11):1339-45.
24. Mohamed Sadek K. Antioxidant and immunostimulant effect of carica papaya linn. Aqueous extract in acrylamide intoxicated rats. Acta Inform Med. 2012;20(3):180-5.
25. Ali AA, Abd Al Haleem EN, Khaleel SA, Sallam AS. Protective effect of cardamonin against acetic acid-induced ulcerative colitis in rats. Pharmacological Reports. 2017;69(2):268-75.
26. El-Abhar HS, Hammad LN, Gawad HS. Modulating effect of ginger extract on rats with ulcerative colitis. Journal of ethnopharmacology. 2008;118(3):367-72.
27. Rahmani, a. H., and y. H. Aldebasi. “Potential role of carica papaya and their active constituents in the prevention and treatment of diseases”. International Journal of Pharmacy and Pharmaceutical sciences. 2016; 8(1):11-15.
28. Oloyede HO, Adaja MC, Ajiboye TO, Salawu MO. Anti-ulcerogenic activity of aqueous extract of Carica papaya seed on indomethacin-induced peptic ulcer in male albino rats. J Integr Med. 2015; 13: 105-14.
29. De Albuquerque CL, Comalada M, Camuesco D, Rodríguez-Cabezas ME, Luiz-Ferreira A, Nieto A, de Souza Brito AR, Zarzuelo A, Gálvez J. Effect of kale and papaya supplementation in colitis induced by trinitrobenzenesulfonic acid in the rat. e-SPEN, the European e-Journal of Clinical Nutrition and Metabolism. 2010; 5(3):e111-6.
30. Erben U, Loddenkemper C, Doerfel K, Spieckermann S, Haller D, Heimesaat MM, Zeitz M, Siegmund B, Kuhl AA. A guide to histomorphological evaluation of intestinal inflammation in mouse models. Int J Clin Exp Pathol. 2014;7(8):4557-76.
31. Lee SH, Kwon JE, Cho ML. Immunological pathogenesis of inflammatory bowel disease. Intest Res. 2018;16(1):26-42. doi: 10.5217/ir.2018.16.1.26.
32. Tanideh N, Nematollahi S, Hosseini S, Hosseinzadeh M, Mehrabani D, Safarpour AR, Sepehrimanesh M, Koohi-Hosseinabadi O, Asma N. The Healing Effect of Hypericumperforatum Extract on Acetic Acid-Induced Ulcerative Colitis in Rat. Annals of Colorectal Research. 2015;2. e25181.
33. Tanideh N, Jamshidzadeh A, Sepehrimanesh M, Hosseinzadeh M, Koohi-Hosseinabadi O, Najibi A, Raam M, Daneshi S, Asadi-Yousefabad SL. Healing acceleration of acetic acid-induced colitis by marigold (Calendula officinalis) in male rats. Saudi J Gastroenterol. 2016;22(1):50-6.
34. Singh SP, Kumar S, Mathan SV, Tomar MS, Singh RK, Verma PK, Kumar A, Kumar S, Singh RP, Acharya A. Therapeutic application of Carica papaya leaf extract in the management of human diseases. Daru. 2020;28(2):735-744.
35. Schley, P.D.; Field, C.J. The immune-enhancing effects of dietary fibres and prebiotics. Br. J. Nutr. 2002; 87:221–30.
36. Suresh K. Antimicrobial and phytochemical investigation of the leaves of Carica papaya L., Cynodondactylon (L.) Pers., Euphorbia hirta L., Meliaazedarach L. and Psidiumguajava L. Ethnobot Leaflets. 2008;12:1184–1191.
37. Nirosha N, Mangalanayaki R. Antibacterial activity of leaves and stem extract of Carica papaya L. Int J Adv Pharm Biol Chem. 2013;2(3):473–476.
38. Schiffrin EJ, Kumar VB, Brown C, Hager C, Van’t Hof MA, Morley JE, Guigoz Y. Systemic inflammatory markers in older persons: The effect of oral nutritional supplementation with prebiotics. J. Nutr. Health Aging 2007; 11:475–479.
39. Looijer-van Langen MA, Dieleman LA. Prebiotics in chronic intestinal inflammation. Inflamm Bowel Dis. 2009;15(3):454-62.